Galafold (MIGALASTAT) 123MG capsule NDC: 71904-0100-01
Ended Awarded
- Contract number
- 36C26124N0482
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89 Part of Amicus Therapeutics, Inc.
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $21,089
Award facts
- Contract value 100% obligated
- $21,089.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order for $21,089.47 was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 to Amicus Therapeutics US, LLC on March 6, 2024. The order is placed against Amicus Therapeutics US, LLC's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration to provide 123mg capsules of Galafold (migalastat), a medication used to treat Fabry disease. No set-aside designation was applied to this order. Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc., will act as the prime contractor in fulfilling delivery of the medication to support healthcare services provided by VISN 21 in Philadelphia, Pennsylvania under the Veterans Health Administration program.
Quick answers
Who was awarded contract 36C26124N0482?
36C26124N0482 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 21 (Veterans Health Administration) on March 6, 2024.
How much is contract 36C26124N0482 worth?
The government has obligated $21,089 on 36C26124N0482.
Is contract 36C26124N0482 an order under another contract?
Yes. 36C26124N0482 is a delivery order under 36F79719D0108, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0482 competed?
The extent of competition for 36C26124N0482 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award